Headlines

Less Than One Hour Before The NASDAQ Open, Sypris Solutions Is Down By 6%

(VIANEWS) – The NASDAQ opens in less than one hour and Sypris Solutions‘s pre-market value is already 6.36% down. Sypris Solutions’s last close was $2.20, 4.35% below its 52-week high of $2.30. The last session, NASDAQ finished with Sypris Solutions (SYPR) rising 1.38% to $2.20. NASDAQ jumped 0.32% to $15,360.29, after three successive sessions in…

Read More

Less Than Two Hours Before The NASDAQ Open, Inovio Pharmaceuticals Is Down By 20%

(VIANEWS) – The NASDAQ opens in less than two hours and Inovio Pharmaceuticals‘s pre-market value is already 20.5% down. Inovio Pharmaceuticals’s last close was $0.69, 64.52% under its 52-week high of $1.95. The last session, NASDAQ ended with Inovio Pharmaceuticals (INO) rising 2.56% to $0.69. NASDAQ jumped 0.32% to $15,360.29, after three sequential sessions in…

Read More

Hostess Brands And Archer On The List Of Winners And Losers Of Monday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Hostess Brands, Rumble, and Vroom. Rank Financial Asset Price Change Updated (EST) 1 Hostess Brands (TWNKW) 3.20 41.59% 2024-01-22 04:44:05 2 Rumble (RUM) 4.74 31.91%…

Read More

Nio Stock Plummets Over 32% In Past 21 Sessions, Sparking Investor Concerns

(VIANEWS) – About Nio Yearly Analysis Technical Analysis Nio Inc. (NIO) has seen its stock value decline significantly in recent months, falling below both its 50-day and 200-day moving averages of EUR7.69 and EUR9.06, indicating a downward trend over both short and long terms. The stock’s daily trading volume was reported as 553,911,520, which represents…

Read More

Pacific Biosciences Stock Plummets 32% In 21 Sessions: What’s Driving The Decline?

(VIANEWS) – Pacific Biosciences of California (NASDAQ: PACB) shares have fallen by 32.87% over 21 sessions, from EUR10.16 on December 19th to EUR6.82 at 12:41 EST on Monday morning despite two consecutive gains on Thursday and Friday; even as the NASDAQ index increased 0.33% to EUR15,360.97 during that same time frame – Pacific Biosciences’ last…

Read More

FibroGen Soars As Positive Trial Results Boost Optimism

(VIANEWS) – About FibroGen Yearly Analysis Technical Analysis Quarter Analysis Sales Growth desfasoarante FibroGen’s sales growth has been staggering with an impressive 5.3% rise during this quarter and even greater 16.4% expansion scheduled for next. Growth Estimates QuartersAccording to current estimates, the company is projected to experience quarterly growth estimates of 37.1% and 46.9% in…

Read More